Natural secretory products of human neural and microvessel endothelial cells: Implications in pathogenic “Spreading” and Alzheimer's disease

By Zhao Yuhai   Cui Jian-Guo   Lukiw Walter  

Molecular Neurobiology, Vol. 34, Iss. 3, 2006-12 ,pp. : 181-192

Humana Press, Inc

Access to resources Recommend Favorite

Gantenerumab for the treatment of Alzheimer's disease

By Delrieu Julien   Ousset Pierre Jean   Vellas Bruno  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 8, 2012-08 ,pp. : 1077-1086

Informa Healthcare

Access to resources Recommend Favorite

Natural Product Inhibitors of Topoisomerases: Review and Docking Study

By  

Current Protein and Peptide Science, Vol. 19, Iss. 3, 2018-01 ,pp. : 275-291

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular basis of Alzheimer’s disease

By Grigorenko A.   Rogaev E.  

Molecular Biology, Vol. 41, Iss. 2, 2007-04 ,pp. : 294-307

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Identification of potent virtual leads to design novel PLK1 inhibitors: pharmacophore modelling, virtual screening and molecular docking studies

By He Lufen   Zhou Lu   Wang Taijin   Li Zicheng   Tang Xiangyang  

Molecular Simulation, Vol. 39, Iss. 8, 2013-07 ,pp. : 640-652

Taylor & Francis Ltd

Access to resources Recommend Favorite